Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−529,376−100.0%Sold outHolders
Q2 2025529,376$4.83M<0.1%−869,606−62.2%ReducedHolders
Q1 20251,398,982$11.1M<0.1%−3,195,373−69.5%ReducedHolders
Q4 20244,594,355$24.9M<0.1%+3,785,557+468.0%AddedHolders
Q3 2024808,798$5.84M<0.1%−581,902−41.8%ReducedHolders
Q2 20241,390,700$15.1M<0.1%+134,255+10.7%AddedHolders
Q1 20241,256,445$23.5M<0.1%+385,881+44.3%AddedHolders
Q4 2023870,564$18.9M<0.1%+6,632+0.8%AddedHolders
Q3 2023863,932$17.8M<0.1%+512,021+145.5%AddedHolders
Q2 2023351,911$16.5M<0.1%−20,741−5.6%ReducedHolders
Q1 2023372,652$15.6M<0.1%−130,983−26.0%ReducedHolders
Q4 2022503,635$19.2M<0.1%+162,920+47.8%AddedHolders
Q3 2022340,715$13.3M<0.1%−232,585−40.6%ReducedHolders
Q2 2022573,300$18.5M<0.1%+8,178+1.4%AddedHolders
Q1 2022565,122$18.7M<0.1%+276,594+95.9%AddedHolders
Q4 2021288,528$12.3M<0.1%−46,312−13.8%ReducedHolders
Q3 2021334,840$14.8M<0.1%−242,876−42.0%ReducedHolders
Q2 2021577,716$32.8M<0.1%+330,541+133.7%AddedHolders
Q1 2021247,175$18.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.